| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
57.54 |
B.V. (₹) |
394.80 |
| Sales(₹ Cr.) |
11,171.72 |
NP (₹ Cr.) |
2,426.73 |
| NP Var% |
40.00 |
Div% |
400.00 |
| CPS(₹) |
47.10 |
EPS (₹) |
42.20 |
| Traded Value(₹ Lakhs) |
610.77 |
52 Week High |
1,735.00 |
| 52 Week Low |
1,066.00 |
Price BSE |
1,735.00 |
| Price NSE |
1,734.00 |
Market Capital (₹ Cr.) |
99,828.07 |
| P/C Ratio |
36.80 |
P/E Ratio |
41.10 |
| Price Vs.BV |
4.39 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
2,781.69 |
| NP(₹ Cr.) |
737.22 |
NP Var % |
32.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
10,713.37 |
| OPM |
23.28 |
NP |
2,069.02 |
| NP Var% |
31.81 |
EPS |
45.29 |
| PE |
38.31 |
|
|